Cargando…
Characteristics of Malignant Pleural Effusion Resident CD8(+) T Cells from a Heterogeneous Collection of Tumors
While T cell-based cancer immunotherapies have shown great promise, there remains a need to understand how individual metastatic tumor environments impart local T cell dysfunction. At advanced stages, cancers that metastasize to the pleural space can result in a malignant pleural effusion (MPE) that...
Autores principales: | Dhupar, Rajeev, Okusanya, Olugbenga T., Eisenberg, Seth H., Monaco, Sara E., Ruffin, Ayana T., Liu, Dongyan, Luketich, James D., Kammula, Udai S., Bruno, Tullia C., Lotze, Michael T., Soloff, Adam C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503595/ https://www.ncbi.nlm.nih.gov/pubmed/32867034 http://dx.doi.org/10.3390/ijms21176178 |
Ejemplares similares
-
Treatment of malignant pleural effusions: the case for localized immunotherapy
por: Donnenberg, Albert D., et al.
Publicado: (2019) -
Prognostic Difference of Pleural versus Distant Metastasis after Surgery for Lung Cancer
por: Joubert, Kyla D., et al.
Publicado: (2021) -
Delayed Chylothorax during Treatment of Follicular Lymphoma with a Malignant Pleural Effusion
por: Ekeke, Chigozirim N., et al.
Publicado: (2020) -
HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions
por: Soloff, Adam C., et al.
Publicado: (2020) -
Intrapleural interleukin-2–expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease
por: Ekeke, Chigozirim N., et al.
Publicado: (2022)